Precision Optics (POCI) Q1 2025 earnings summary

Executive summary

• Q1 FY2025 revenue was $4.2 million, down 2.9% year-over-year, with a net loss of $1.3 million compared to a $464,000 loss in the prior year.

• Gross margin declined to 26.6% from 33.9% year-over-year, mainly due to underutilization, product mix, and production delays.

• Strategic focus on single-use endoscopes is yielding results, with two major production orders transitioning from development to manufacturing.

• R&D and SG&A expenses increased, reflecting investment in new technologies and higher recruitment, consulting, and IT costs.

• Long-term growth outlook remains robust, supported by a strong product development pipeline and customer engagement.

Financial highlights

• Revenue for Q1 FY2025 was $4,197,053, down from $4,321,255 in Q1 FY2024.

• Gross profit fell to $1,117,330 from $1,463,611 year-over-year.

• Net loss widened to $1,311,247 from $464,415 year-over-year.

• Adjusted EBITDA was negative $1 million, versus negative $245,000 last year.

• EPS was $(0.21) compared to $(0.08) in the prior year period.

Outlook and guidance

• Q2 revenue expected to exceed $5 million, with continued growth anticipated in the second half of FY2025.

• Adjusted EBITDA break-even expected at quarterly revenue of approximately $5.5 million.

• Production revenue projected to grow from $6.6 million in FY2024 to over $10 million in FY2025.

• Product development revenue expected to be flat in FY2025, resuming 20%-30% annual growth in FY2026.

• Management expects the customer pipeline to expand as development projects transition to production and new projects enter development.